标题
Systemic Lupus Erythematosus and COVID-19
作者
关键词
-
出版物
Current Rheumatology Reports
Volume 25, Issue 10, Pages 192-203
出版商
Springer Science and Business Media LLC
发表日期
2023-07-21
DOI
10.1007/s11926-023-01110-z
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Short- and mid-term outcomes in systemic lupus erythematosus patients presenting with disease exacerbation after SARS-CoV-2 mRNA vaccination: A cohort study from Puerto Rico
- (2023) Ariana González-Meléndez et al. LUPUS
- Effect of Systemic Lupus and Immunosuppressives on COVID Vaccination Antibody Response
- (2023) Michelle Petri et al. ARTHRITIS CARE & RESEARCH
- Risk of autoimmune diseases in patients with COVID-19: A retrospective cohort study
- (2023) Renin Chang et al. EClinicalMedicine
- Real world effectiveness of tixagevimab/cilgavimab (Evusheld) in the Omicron era
- (2023) Benjamin Chen et al. PLoS One
- Sustained cell-mediated but not humoral responses in rituximab-treated rheumatic patients after vaccination against SARS-CoV-2
- (2023) Κonstantinos Thomas et al. RHEUMATOLOGY
- Risks of mortality and severe coronavirus disease 19 (COVID-19) outcomes in patients with or without systemic lupus erythematosus
- (2023) Sebastian Bruera et al. Lupus Science & Medicine
- Immunogenicity of BNT162b2 vaccine against the Alpha and Delta variants in immunocompromised patients with systemic inflammatory diseases
- (2022) Jerome Hadjadj et al. ANNALS OF THE RHEUMATIC DISEASES
- Characteristics associated with poor COVID-19 outcomes in individuals with systemic lupus erythematosus: data from the COVID-19 Global Rheumatology Alliance
- (2022) Manuel Francisco Ugarte-Gil et al. ANNALS OF THE RHEUMATIC DISEASES
- Safety of vaccination against SARS-CoV-2 in people with rheumatic and musculoskeletal diseases: results from the EULAR Coronavirus Vaccine (COVAX) physician-reported registry
- (2022) Pedro M Machado et al. ANNALS OF THE RHEUMATIC DISEASES
- Third COVID-19 vaccine dose with BNT162b2 in patients with ANCA-associated vasculitis
- (2022) Claudius Speer et al. ANNALS OF THE RHEUMATIC DISEASES
- Systemic lupus erythematosus with acute pancreatitis and vasculitic rash following COVID-19 vaccine: a case report and literature review
- (2022) Alrashdi Mousa N et al. CLINICAL RHEUMATOLOGY
- Early experience of COVID‐19 vaccine‐related adverse events among adolescents and young adults with rheumatic diseases: A single‐center study
- (2022) Fatih Haslak et al. International Journal of Rheumatic Diseases
- Safety Profile and Low Risk of Disease Relapse After BNT162b2 mRNA SARS-CoV-2 Vaccination in Patients With Rare Rheumatic Diseases
- (2022) Marco Fornaro et al. JOURNAL OF RHEUMATOLOGY
- The T cell immune response against SARS-CoV-2
- (2022) Paul Moss NATURE IMMUNOLOGY
- Safety and immunogenicity of BNT162b2 mRNA COVID-19 vaccine in adolescents with rheumatic diseases treated with immunomodulatory medications
- (2022) Merav Heshin-Bekenstein et al. RHEUMATOLOGY
- COVID‐19 vaccination in patients with rheumatic diseases: Vaccination rates, patient perspectives, and side effects
- (2022) Yan Kiu Li et al. Immunity Inflammation and Disease
- EULAR recommendations for the management and vaccination of people with rheumatic and musculoskeletal diseases in the context of SARS-CoV-2: the November 2021 update
- (2022) Robert B M Landewé et al. ANNALS OF THE RHEUMATIC DISEASES
- Seroprevalence of SARS-CoV-2-specific antibodies and vaccination-related adverse events in systemic lupus erythematosus and rheumatoid arthritis
- (2022) Peng Wang et al. BIOMEDICINE & PHARMACOTHERAPY
- Systemic lupus erythematosus in the light of the COVID-19 pandemic: infection, vaccination, and impact on disease management
- (2022) Pankti Mehta et al. CLINICAL RHEUMATOLOGY
- High T-cell response rate after COVID-19 vaccination in belimumab and rituximab recipients
- (2022) Martina Fabris et al. JOURNAL OF AUTOIMMUNITY
- Effect of chronic hydroxychloroquine use on COVID-19 risk in patients with rheumatoid arthritis and systemic lupus erythematosus: a multicenter retrospective cohort
- (2022) Ismail A. Walbi et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Frequency and severity of COVID‐19 in patients with various rheumatic diseases treated regularly with colchicine or hydroxychloroquine
- (2022) Mert Oztas et al. JOURNAL OF MEDICAL VIROLOGY
- Time Since Rituximab Treatment Is Essential for Developing a Humoral Response to COVID-19 mRNA Vaccines in Patients With Rheumatic Diseases
- (2022) Anne Troldborg et al. JOURNAL OF RHEUMATOLOGY
- Intramuscular AZD7442 (Tixagevimab–Cilgavimab) for Prevention of Covid-19
- (2022) Myron J. Levin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Whole blood drug levels do not correlate with QTc intervals in hydroxychloroquine-treated systemic lupus erythematosus patients
- (2022) H Michael Belmont et al. RHEUMATOLOGY
- The Impact of Anti-SARS-CoV-2 Vaccine in Patients with Systemic Lupus Erythematosus: A Multicentre Cohort Study
- (2022) Maria Gerosa et al. Vaccines
- Comparison of Immunogenicity and Safety of Inactivated, Adenovirus-Vectored, and Heterologous Adenovirus-Vectored/mRNA Vaccines in Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis: A Prospective Cohort Study
- (2022) Theerada Assawasaksakul et al. Vaccines
- The Immunogenicity and Safety of Three Types of SARS-CoV-2 Vaccines in Adult Patients with Immune-Mediated Inflammatory Diseases: A Longitudinal Cohort Study
- (2022) Ni Tien et al. Biomedicines
- Humoral responses after second and third SARS-CoV-2 vaccination in patients with immune-mediated inflammatory disorders on immunosuppressants: a cohort study
- (2022) Luuk Wieske et al. Lancet Rheumatology
- COVID-19 vaccine uptake among patients with systemic lupus erythematosus in the American Midwest: The Lupus Midwest Network (LUMEN)
- (2022) Baptiste Chevet et al. JOURNAL OF RHEUMATOLOGY
- Belimumab is not associated with COVID-19 mRNA vaccination failure in systemic lupus erythematosus
- (2022) Simone Cosima Boedecker-Lips et al. RHEUMATOLOGY
- Projecting the SARS-CoV-2 transition from pandemicity to endemicity: Epidemiological and immunological considerations
- (2022) Lily E. Cohen et al. PLoS Pathogens
- Medium-term impact of the SARS-CoV-2 mRNA vaccine against disease activity in patients with systemic lupus erythematosus
- (2022) Tsuneyasu Yoshida et al. Lupus Science & Medicine
- Immunogenicity and safety of a fourth COVID-19 vaccination in rituximab-treated patients: an open-label extension study
- (2022) Daniel Mrak et al. ANNALS OF THE RHEUMATIC DISEASES
- Global case fatality rate from COVID‐19 has decreased by 96.8% during 2.5 years of the pandemic
- (2022) Nobuyuki Horita et al. JOURNAL OF MEDICAL VIROLOGY
- Factors associated with poor outcomes in SLE patients with COVID-19: Data from ReumaCoV-Brazil register
- (2022) Joana S Carvalho et al. LUPUS
- COVID-19 vaccination in systemic lupus erythematosus: a systematic review for effectiveness, immunogenicity, flares and acceptance
- (2022) Shaun Ye Song Tan et al. RHEUMATOLOGY
- Association Between Race/Ethnicity and COVID ‐19 Outcomes in Systemic Lupus Erythematosus ( SLE ) Patients from the United States: Data from the COVID ‐19 Global Rheumatology Alliance
- (2022) Manuel F Ugarte‐Gil et al. ARTHRITIS CARE & RESEARCH
- Glucocorticoids’ treatment impairs the medium-term immunogenic response to SARS-CoV-2 mRNA vaccines in Systemic Lupus Erythematosus patients
- (2022) Silvia Garcia-Cirera et al. Scientific Reports
- COVID-19 and systemic lupus erythematosus genetics: A balance between autoimmune disease risk and protection against infection
- (2022) Yuxuan Wang et al. PLoS Genetics
- Characteristics of SARS-CoV-2 Infection in an Actively Monitored Cohort of Patients with Lupus Nephritis
- (2022) Bogdan Obrișcă et al. Biomedicines
- Hydroxychloroquine blocks SARS-CoV-2 entry into the endocytic pathway in mammalian cell culture
- (2022) Zixuan Yuan et al. Communications Biology
- Early experience with tixagevimab/cilgavimab pre-exposure prophylaxis in patients with immune-mediated inflammatory disease undergoing B cell depleting therapy and those with inborn errors of humoral immunity
- (2022) Cassandra Calabrese et al. RMD Open
- Safety and tolerance of vaccines against SARS-CoV-2 infection in systemic lupus erythematosus: results from the COVAD study
- (2022) R Naveen et al. RHEUMATOLOGY
- American College of Rheumatology Guidance for COVID ‐19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 5
- (2022) Jeffrey R. Curtis et al. Arthritis & Rheumatology
- Immunocompromised Patients with Protracted COVID-19: a Review of “Long Persisters”
- (2022) Veronica Dioverti et al. Current Transplantation Reports
- Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry
- (2021) Anja Strangfeld et al. ANNALS OF THE RHEUMATIC DISEASES
- Risk of Severe COVID-19 Infection in Patients With Inflammatory Rheumatic Diseases
- (2021) Javier Bachiller-Corral et al. JOURNAL OF RHEUMATOLOGY
- Why is it so hard to investigate the rare side effects of COVID vaccines?
- (2021) Ariana Remmel NATURE
- B-cell targeted therapy is associated with severe COVID-19 among patients with inflammatory arthritides: a 1-year multicentre study in 1116 successive patients receiving intravenous biologics
- (2021) Renaud Felten et al. ANNALS OF THE RHEUMATIC DISEASES
- New onset systemic lupus erythematosus opening as class V lupus nephritis after COVID-19 vaccination
- (2021) María Fernanda Zavala-Miranda et al. KIDNEY INTERNATIONAL
- The Emergence of new-onset SLE following SARS-CoV-2 vaccination
- (2021) A Nune et al. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE
- Local and systemic reactogenicity of COVID-19 vaccine BNT162b2 in patients with systemic lupus erythematosus and rheumatoid arthritis
- (2021) Lars Erik Bartels et al. RHEUMATOLOGY INTERNATIONAL
- Systemic lupus erythematosus after COVID‐19 vaccination: A case report
- (2021) Sakshi Patil et al. Journal of Cosmetic Dermatology
- Evaluation of Immune Response and Disease Status in SLE Patients Following SARS‐CoV‐2 Vaccination
- (2021) Peter M. Izmirly et al. Arthritis & Rheumatology
- Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey
- (2021) Sebastian Eduardo Sattui et al. RMD Open
- Tolerance of COVID-19 vaccination in patients with systemic lupus erythematosus: the international VACOLUP study
- (2021) Renaud Felten et al. Lancet Rheumatology
- Adverse events after first COVID-19 vaccination in patients with autoimmune diseases
- (2021) Laura Boekel et al. Lancet Rheumatology
- COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study
- (2021) Jérôme Avouac et al. Lancet Rheumatology
- High-titre convalescent plasma therapy for an immunocompromised patient with systemic lupus erythematosus with protracted SARS-CoV-2 infection
- (2021) Sara Moutinho-Pereira et al. BMJ Case Reports
- BNT162b2 vaccine-induced humoral and cellular responses against SARS-CoV-2 variants in systemic lupus erythematosus
- (2021) Quentin Moyon et al. ANNALS OF THE RHEUMATIC DISEASES
- Impact of the COVID-19 pandemic in patients with systemic lupus erythematosus throughout one year
- (2021) Giuseppe A. Ramirez et al. CLINICAL IMMUNOLOGY
- Side effects and flares risk after SARS-CoV-2 vaccination in patients with systemic lupus erythematosus
- (2021) Ernesto Zavala-Flores et al. CLINICAL RHEUMATOLOGY
- Adverse events and disease flares after SARS-CoV-2 vaccination in patients with systemic lupus erythematosus
- (2021) Medha Barbhaiya et al. CLINICAL RHEUMATOLOGY
- New-onset Evans syndrome associated with systemic lupus erythematosus after BNT162b2 mRNA COVID-19 vaccination
- (2021) Daisuke Hidaka et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients’ subgroups
- (2021) Clodoveo Ferri et al. JOURNAL OF AUTOIMMUNITY
- Improving COVID-19 Vaccine Coverage in Patients With Autoimmune and Inflammatory Diseases
- (2021) Tiphaine Goulenok et al. JOURNAL OF RHEUMATOLOGY
- Subacute cutaneous lupus erythematosus induction after SARS‐CoV‐2 vaccine in a patient with primary biliary cholangitis
- (2021) C. Zengarini et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Associations of Disease-Modifying Therapies With COVID-19 Severity in Multiple Sclerosis
- (2021) Steve Simpson-Yap et al. NEUROLOGY
- Clinical characteristics and COVID-19 outcomes in a regional cohort of pediatric patients with rheumatic diseases
- (2021) Daniel Clemente et al. Pediatric Rheumatology
- Seroprevalence and clinical outcomes of SARS-CoV-2 in paediatric patients with rheumatic disease
- (2021) Heather M Walters et al. RHEUMATOLOGY
- Impact of distinct therapies on antibody response to SARS‐CoV ‐2 vaccine in systemic lupus erythematosus
- (2021) Emily F. N. Yuki et al. ARTHRITIS CARE & RESEARCH
- Rituximab impairs B‐cell response but not T‐cell response to COVID ‐19 vaccine in auto‐immune diseases
- (2021) Samuel Bitoun et al. Arthritis & Rheumatology
- SARS‐CoV ‐2 Infection and COVID ‐19 Outcomes in Rheumatic Disease: A Systematic Literature Review And Meta‐Analysis
- (2021) Richard Conway et al. Arthritis & Rheumatology
- Chronic use of hydroxychloroquine did not protect against COVID-19 in a large cohort of patients with rheumatic diseases in Brazil
- (2021) Gecilmara Salviato Pileggi et al. Advances in Rheumatology
- All-cause mortality in systemic rheumatic diseases under treatment compared with the general population, 2015–2019
- (2021) Vasiliki-Kalliopi Bournia et al. RMD Open
- Humoral and cellular immune responses to two and three doses of SARS-CoV-2 vaccines in rituximab-treated patients with rheumatoid arthritis: a prospective, cohort study
- (2021) Ingrid Jyssum et al. Lancet Rheumatology
- Rituximab during the COVID-19 pandemic: time to discuss treatment options with patients
- (2021) L Boekel et al. Lancet Rheumatology
- Long-term use of immunosuppressive medicines and in-hospital COVID-19 outcomes: a retrospective cohort study using data from the National COVID Cohort Collaborative
- (2021) Kathleen M Andersen et al. Lancet Rheumatology
- Clinical Characteristics of Coronavirus Disease 2019 in China
- (2020) Wei-jie Guan et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Novel Coronavirus from Patients with Pneumonia in China, 2019
- (2020) Na Zhu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Are patients with systemic lupus erythematosus at increased risk for COVID-19?
- (2020) Ennio Giulio Favalli et al. ANNALS OF THE RHEUMATIC DISEASES
- Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry
- (2020) Milena Gianfrancesco et al. ANNALS OF THE RHEUMATIC DISEASES
- The proximal origin of SARS-CoV-2
- (2020) Kristian G. Andersen et al. NATURE MEDICINE
- Systematic analysis of COVID-19 infection and symptoms in a systemic lupus erythematosus population: correlation with disease characteristics, hydroxychloroquine use and immunosuppressive treatments
- (2020) Zoé Gendebien et al. ANNALS OF THE RHEUMATIC DISEASES
- Coronavirus disease 2019 (COVID-19) in autoimmune and inflammatory conditions: clinical characteristics of poor outcomes
- (2020) Fernando Montero et al. RHEUMATOLOGY INTERNATIONAL
- Hydroxychloroquine: A comprehensive review and its controversial role in coronavirus disease 2019
- (2020) Pankaj Bansal et al. ANNALS OF MEDICINE
- Antirheumatic drugs, B cell depletion and critical COVID-19: correspondence on ‘Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine’ by Mathian et al
- (2020) Quirin Notz et al. ANNALS OF THE RHEUMATIC DISEASES
- SARS-CoV-2 vaccines in development
- (2020) Florian Krammer NATURE
- Inborn errors of type I IFN immunity in patients with life-threatening COVID-19
- (2020) Qian Zhang et al. SCIENCE
- Autoantibodies against type I IFNs in patients with life-threatening COVID-19
- (2020) Paul Bastard et al. SCIENCE
- Knowledge and attitudes about influenza vaccination in rheumatic diseases patients
- (2020) Gabriel Figueroa-Parra et al. Human Vaccines & Immunotherapeutics
- Effect of hydroxychloroquine pre-exposure on infection with SARS-CoV-2 in rheumatic disease patients: a population-based cohort study
- (2020) Sun-Young Jung et al. CLINICAL MICROBIOLOGY AND INFECTION
- Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host
- (2020) Bina Choi et al. NEW ENGLAND JOURNAL OF MEDICINE
- 2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases
- (2019) Victoria Furer et al. ANNALS OF THE RHEUMATIC DISEASES
- Vaccination coverage in systemic lupus erythematosus—a cross-sectional analysis of the German long-term study (LuLa cohort)
- (2018) Gamal Chehab et al. RHEUMATOLOGY
- Epidemiology of systemic lupus erythematosus
- (2017) Guillermo J. Pons-Estel et al. Expert Review of Clinical Immunology
- Attitude, knowledge and factors associated with influenza and pneumococcal vaccine uptake in a large cohort of patients with secondary immune deficiency
- (2015) Paul Loubet et al. VACCINE
- Burden of Serious Infections in Adults With Systemic Lupus Erythematosus: A National Population-Based Study, 1996-2011
- (2015) Maria G. Tektonidou et al. ARTHRITIS CARE & RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started